Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) EBT Margin (2016 - 2023)

Aethlon Medical filings provide 13 years of EBT Margin readings, the most recent being 429.6% for Q1 2023.

  • On a quarterly basis, EBT Margin rose 2843361.0% to 429.6% in Q1 2023 year-over-year; TTM through Mar 2023 was 2070.21%, a 147236.0% increase, with the full-year FY2023 number at 2070.14%, up 147239.0% from a year prior.
  • EBT Margin hit 429.6% in Q1 2023 for Aethlon Medical, up from 28863.21% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 212.0% in Q4 2019 to a low of 28863.21% in Q1 2022.
  • Median EBT Margin over the past 5 years was 1590.23% (2021), compared with a mean of 5701.32%.
  • Biggest five-year swings in EBT Margin: tumbled -2224788bps in 2022 and later surged 2843361bps in 2023.
  • Aethlon Medical's EBT Margin stood at 212.0% in 2019, then crashed by -85bps to 391.31% in 2020, then plummeted by -3674bps to 14768.63% in 2021, then tumbled by -95bps to 28863.21% in 2022, then surged by 99bps to 429.6% in 2023.
  • The last three reported values for EBT Margin were 429.6% (Q1 2023), 28863.21% (Q1 2022), and 14768.63% (Q4 2021) per Business Quant data.